跳至主要内容
临床试验/NCT00219414
NCT00219414已完成4 期

Study for the Treatment of Ulcerative Colitis With Adacolumn (Companion to US Study 512-04-205)

Otsuka Frankfurt Research Institute GmbH0 个研究点目标入组 42 人开始时间: 2005年6月1日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
42
主要终点
Primary Outcomes: Effectiveness will be primarily evaluated at Week 12 by disease activity index (DAI) score; Safety will be evaluated by determining the frequency and severity of adverse events.

研究概览

简要总结

The purpose of the study is to demonstrate the safety and effectiveness of the Adacolumn Apheresis System to treat the signs and symptoms of ulcerative colitis.

详细描述

Study Type: Interventional Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Primary Outcomes: Effectiveness will be primarily evaluated at Week 12 by disease activity index (DAI) score; Safety will be evaluated by determining the frequency and severity of adverse events.

次要结局

未报告次要终点

研究者

发起方
Otsuka Frankfurt Research Institute GmbH
申办方类型
Industry

相似试验

Study for the Treatment of Ulcerative Colitis With... | 临床试验